Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics

Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators. Oncolytic viruses (OV) are an integral pillar of immuno-oncology and hold potenti...

Full description

Bibliographic Details
Main Authors: Virginia Corbett, Paul Hallenbeck, Piotr Rychahou, Aman Chauhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
seneca valley virus
oncolytic virus
drug development
TEM8/ANTXR1
neuroendocrine tumors
neuroendocrine carcinomas
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.930207/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.930207/full

Similar Items